RU2372324C2 - Новые нитрофенилипритные и нитрофенилазиридиновые спирты и их соответствующие фосфаты и их применение в качестве нацеленных цитотоксических средств - Google Patents
Новые нитрофенилипритные и нитрофенилазиридиновые спирты и их соответствующие фосфаты и их применение в качестве нацеленных цитотоксических средств Download PDFInfo
- Publication number
- RU2372324C2 RU2372324C2 RU2006118785/04A RU2006118785A RU2372324C2 RU 2372324 C2 RU2372324 C2 RU 2372324C2 RU 2006118785/04 A RU2006118785/04 A RU 2006118785/04A RU 2006118785 A RU2006118785 A RU 2006118785A RU 2372324 C2 RU2372324 C2 RU 2372324C2
- Authority
- RU
- Russia
- Prior art keywords
- amino
- compound
- ethyl
- formula
- carbonyl
- Prior art date
Links
- 0 *c(c(*)c1)cc(*)c1[N+]([O-])=O Chemical compound *c(c(*)c1)cc(*)c1[N+]([O-])=O 0.000 description 8
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/09—Esters of phosphoric acids
- C07F9/091—Esters of phosphoric acids with hydroxyalkyl compounds with further substituents on alkyl
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/28—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
- C07C237/32—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having the nitrogen atom of the carboxamide group bound to an acyclic carbon atom of a hydrocarbon radical substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/63—Esters of sulfonic acids
- C07C309/64—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms
- C07C309/65—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms of a saturated carbon skeleton
- C07C309/66—Methanesulfonates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
- C07C317/48—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton the carbon skeleton being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D203/00—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom
- C07D203/04—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D203/06—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D203/08—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring nitrogen atom
- C07D203/14—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring nitrogen atom with carbocyclic rings directly attached to the ring nitrogen atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Radiation-Therapy Devices (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NZ529249 | 2003-10-31 | ||
| NZ529249A NZ529249A (en) | 2003-10-31 | 2003-10-31 | Novel nitrophenyl mustard and nitrophenylaziridine alcohols and their corresponding phosphates and their use as targeted cytotoxic |
| NZ535618 | 2004-09-28 | ||
| NZ53561804 | 2004-09-28 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU2006118785A RU2006118785A (ru) | 2007-12-10 |
| RU2372324C2 true RU2372324C2 (ru) | 2009-11-10 |
Family
ID=34555019
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2006118785/04A RU2372324C2 (ru) | 2003-10-31 | 2004-10-29 | Новые нитрофенилипритные и нитрофенилазиридиновые спирты и их соответствующие фосфаты и их применение в качестве нацеленных цитотоксических средств |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US7629332B2 (https=) |
| EP (1) | EP1680394A4 (https=) |
| JP (1) | JP4760712B2 (https=) |
| KR (1) | KR101167335B1 (https=) |
| AU (1) | AU2004285831B2 (https=) |
| BR (1) | BRPI0416085A (https=) |
| CA (1) | CA2544335A1 (https=) |
| IL (1) | IL175000A0 (https=) |
| RU (1) | RU2372324C2 (https=) |
| WO (1) | WO2005042471A1 (https=) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7629332B2 (en) * | 2003-10-31 | 2009-12-08 | Auckland Uniservices Limited | Nitrophenyl mustard and nitrophenylaziridine alcohols and their corresponding phosphates and their use as targeted cytotoxic agents |
| NZ549659A (en) * | 2006-09-04 | 2008-12-24 | Auckland Uniservices Ltd | Processes of preparing asymmetric dinitrobenzamide mustard compounds, intermediate compounds useful therein and products obtained therefrom |
| WO2008033039A1 (en) * | 2006-09-11 | 2008-03-20 | Adam Vorn Patterson | Cancer treatment |
| NZ549831A (en) * | 2006-09-11 | 2009-03-31 | Auckland Uniservices Ltd | Combination of docetaxel and a nitrophenyl phosphate derivative for the treatment of cancer |
| WO2008033041A1 (en) * | 2006-09-11 | 2008-03-20 | Auckland Uniservices Limited | Cancer treatment |
| EP2114157B1 (en) | 2006-12-26 | 2021-05-26 | ImmunoGenesis, Inc. | Phosphoramidate alkylator prodrug for the treatment of cancer |
| WO2009140553A2 (en) * | 2008-05-15 | 2009-11-19 | Threshold Pharmaceuticals, Inc. | Hypoxia activated drugs of nitrogen mustard alkylators |
| WO2010044685A1 (en) * | 2008-10-17 | 2010-04-22 | Auckland Uniservices Limited | Nitrophenyl mustard alcohols, their corresponding phosphates and their use as targeted cytotoxic agents |
| JP5765634B2 (ja) | 2008-10-21 | 2015-08-19 | スレッシュホールド ファーマシューティカルズ， インコーポレイテッド | 低酸素活性化型プロドラッグを用いるがんの処置 |
| CN101723932B (zh) | 2008-10-31 | 2013-11-20 | 北京以岭生物工程技术有限公司 | 硝基吡啶乙烯亚胺化合物、其药物组合物及其制备方法和用途 |
| WO2012009288A2 (en) | 2010-07-12 | 2012-01-19 | Threshold Pharmaceuticals, Inc. | Administration of hypoxia activated prodrugs and antiangiogenic agents for the treatment of cancer |
| US10357577B2 (en) | 2010-07-16 | 2019-07-23 | Auckland Uniservices Limited | Bacterial nitroreductase enzymes and methods relating thereto |
| CN104039328B (zh) * | 2011-11-11 | 2018-10-09 | 米伦纽姆医药公司 | 对蛋白酶体抑制剂的反应的生物标记 |
| WO2013096687A1 (en) | 2011-12-22 | 2013-06-27 | Threshold Pharmaceuticals, Inc. | Administration of hypoxia activated prodrugs in combination with chk1 inhibitors for treating cancer |
| WO2014007650A1 (en) * | 2011-12-23 | 2014-01-09 | Auckland Uniservices Limited | Compounds and methods for selective imaging and/or ablation |
| US10202408B2 (en) | 2012-08-23 | 2019-02-12 | Health Innovation Ventures B.V. | Prodrugs and methods of use thereof |
| CN105051004B (zh) * | 2012-08-23 | 2017-12-05 | 健康创新企业私人有限责任公司 | 新型前体药物及其使用方法 |
| WO2014062856A1 (en) | 2012-10-16 | 2014-04-24 | Halozyme, Inc. | Hypoxia and hyaluronan and markers thereof for diagnosis and monitoring of diseases and conditions and related methods |
| US20160158253A1 (en) | 2013-07-26 | 2016-06-09 | Threshold Pharmaceuticals, Inc. | Treatment of pancreatic cancer with a combination of a hypoxia-activated prodrug and a taxane |
| WO2016210175A1 (en) | 2015-06-24 | 2016-12-29 | Threshold Pharmaceuticals, Inc. | Aziridine containing dna alkylating agents |
| US10348685B2 (en) * | 2016-04-29 | 2019-07-09 | Nicira, Inc. | Priority allocation for distributed service rules |
| CN108571241B (zh) * | 2017-03-14 | 2021-08-17 | 福特环球技术公司 | 用于推按式闩锁类型车辆抽屉的惯性锁系统 |
| WO2019125184A1 (en) | 2017-12-19 | 2019-06-27 | Auckland Uniservices Limited | Use of biomarker in cancer therapy |
| WO2019190331A1 (en) * | 2018-03-29 | 2019-10-03 | Achilles Medical Limited | Prodrug compounds activated by akr1c3 and their use for treating hyperproliferative disorders |
| WO2019229195A1 (en) * | 2018-05-30 | 2019-12-05 | Convert Pharmaceuticals S.A. | Prodrugs and medical uses thereof |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SU196819A1 (https=) * | Донецкий филиал Всесоюзного каучно ксследовательского института химических реактивов , особо чистых химических веществ | |||
| WO1993011099A1 (en) * | 1991-11-28 | 1993-06-10 | Cancer Research Campaign Technology Limited | Nitroaniline derivatives and their use as antitumor agents |
| WO2000013683A2 (en) * | 1998-09-07 | 2000-03-16 | Cancer Research Campaign Technology Limited | Novel nitrophenylaziridine compounds and their use as prodrugs |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003022274A2 (en) * | 2001-09-13 | 2003-03-20 | Synta Pharmaceuticals Corp. | 2-aroylimidazole compounds for treating cancer |
| NZ521851A (en) * | 2002-10-08 | 2005-02-25 | Auckland Uniservices Ltd | Nitroaniline-based unsymmetrical mustard alkylating agents for gene dependent enzyme prodrug therapy |
| US7629332B2 (en) * | 2003-10-31 | 2009-12-08 | Auckland Uniservices Limited | Nitrophenyl mustard and nitrophenylaziridine alcohols and their corresponding phosphates and their use as targeted cytotoxic agents |
-
2004
- 2004-10-29 US US10/577,078 patent/US7629332B2/en not_active Expired - Fee Related
- 2004-10-29 CA CA002544335A patent/CA2544335A1/en not_active Abandoned
- 2004-10-29 EP EP04817434A patent/EP1680394A4/en not_active Withdrawn
- 2004-10-29 BR BRPI0416085-1A patent/BRPI0416085A/pt not_active IP Right Cessation
- 2004-10-29 RU RU2006118785/04A patent/RU2372324C2/ru not_active IP Right Cessation
- 2004-10-29 WO PCT/NZ2004/000275 patent/WO2005042471A1/en not_active Ceased
- 2004-10-29 JP JP2006537921A patent/JP4760712B2/ja not_active Expired - Fee Related
- 2004-10-29 KR KR1020067010566A patent/KR101167335B1/ko not_active Expired - Fee Related
- 2004-10-29 AU AU2004285831A patent/AU2004285831B2/en not_active Ceased
-
2006
- 2006-04-11 IL IL175000A patent/IL175000A0/en unknown
-
2009
- 2009-08-11 US US12/461,419 patent/US20100010094A1/en not_active Abandoned
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SU196819A1 (https=) * | Донецкий филиал Всесоюзного каучно ксследовательского института химических реактивов , особо чистых химических веществ | |||
| WO1993011099A1 (en) * | 1991-11-28 | 1993-06-10 | Cancer Research Campaign Technology Limited | Nitroaniline derivatives and their use as antitumor agents |
| WO2000013683A2 (en) * | 1998-09-07 | 2000-03-16 | Cancer Research Campaign Technology Limited | Novel nitrophenylaziridine compounds and their use as prodrugs |
Non-Patent Citations (1)
| Title |
|---|
| W.R.WILSON et al., Cancer Research, 2002, 62(5), p.1425-1432. B.D.Palmer et al. Journal of Medicinal Chemestry (1996), 39(13), p.2518-2528. G.M.Anlezark et al., Boichemical Pharmacology (1995), 50(5), p.609-618. A.H.Khan and W.C.J.Ross, Chemico-Biological Interactions (1971), 4(1), p.11-22. * |
Also Published As
| Publication number | Publication date |
|---|---|
| US20070032455A1 (en) | 2007-02-08 |
| IL175000A0 (en) | 2006-08-20 |
| EP1680394A1 (en) | 2006-07-19 |
| JP4760712B2 (ja) | 2011-08-31 |
| JP2007509928A (ja) | 2007-04-19 |
| US7629332B2 (en) | 2009-12-08 |
| AU2004285831B2 (en) | 2011-09-15 |
| AU2004285831A1 (en) | 2005-05-12 |
| US20100010094A1 (en) | 2010-01-14 |
| KR101167335B1 (ko) | 2012-07-19 |
| CA2544335A1 (en) | 2005-05-12 |
| RU2006118785A (ru) | 2007-12-10 |
| WO2005042471A1 (en) | 2005-05-12 |
| KR20070006677A (ko) | 2007-01-11 |
| BRPI0416085A (pt) | 2007-01-02 |
| EP1680394A4 (en) | 2006-10-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2372324C2 (ru) | Новые нитрофенилипритные и нитрофенилазиридиновые спирты и их соответствующие фосфаты и их применение в качестве нацеленных цитотоксических средств | |
| ES2539383T3 (es) | Análogos arilesfingosina 1-fosfato bicíclicos | |
| TW470750B (en) | Reversible cysteine protease inhibitors | |
| JP2010265272A (ja) | ニトロアニリン系のアルキル化剤およびそれらのプロドラッグとしての使用 | |
| US10245246B2 (en) | β-substituted β-amino acids and analogs as chemotherapeutic agents | |
| JP2006502214A6 (ja) | ニトロアニリン系のアルキル化剤およびそれらのプロドラッグとしての使用 | |
| JP3009196B2 (ja) | 抗ウイルス活性を有する薬剤、燐脂質誘導体及びその製造方法 | |
| US20100121091A1 (en) | Processes of preparing asymmetric dinitrobenzamide mustard compounds, intermediate compounds useful therein and products obtained therefrom | |
| CN1902159B (zh) | 新的硝基苯基氮芥和硝基苯基氮丙啶醇以及它们相应的磷酸酯和作为靶向细胞毒素剂的用途 | |
| WO2020081917A1 (en) | Βeta-catenin and b-cell lymphoma 9 (bcl9) inhibitors | |
| US5750782A (en) | Nitroaniline derivatives and their use as anti-tumour agents | |
| MXPA06004635A (en) | Novel nitrophenyl mustard and nitrophenylaziridine alcohols and their corresponding phosphates and their use as targeted cytotoxic agents | |
| EP0172059B1 (fr) | Nouveaux dérivés de l'oxaazaphosphorine, leur procédé de préparation et les compositions pharmaceutiques les renfermant |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | The patent is invalid due to non-payment of fees |
Effective date: 20131030 |